The combination of OCT and MRI can help provide an improved sense of clarity when managing MINOCA patients, according to new data presented at ACC.26 in New Orleans.

Late-breaking data out of ACC.26 suggest a more aggressive treatment approach for these patients could be beneficial. 

Gregg Stone, MD, spoke to Cardiovascular Business about the lessons he and his colleagues learned from the STEMI DTU trial.

At the end of the day, one electrophysiologist explained, these decisions should still be made on a case-by-case basis.

SCAI President Srihari S. Naidu, MD, a veteran interventional cardiologist, made a major impact on the group—and cardiology as a whole—over the last 12 months. 

Clinicians may need to broaden their diagnostic approach when treating and managing patients with resistant hypertension. 

More than 7,000 physicians from a wide variety of healthcare specialties are already participating in the project.

A majority of deaths from Friedreich's ataxia are associated with heart complications. A new treatment years in the making could provide some much-needed relief.